ADVFN - Advanced Financial Network.
HOME» NYSE » O » OCR Stock Price » OCR Stock News

Omnicare Share News

 Omnicare Inc. Stock Price
OCR Stock Price
 Omnicare Inc. Stock Chart
OCR Stock Chart
 Omnicare Inc. Stock News
OCR Stock News
 Omnicare Inc. Company Information
OCR Company Information
 Omnicare Inc. Stock Trades
OCR Stock Trades

Omnicare 1Q Profit Declines 42% As Margins Fall

DOW JONES NEWSWIRES Omnicare Inc.'s (OCR) first-quarter earnings fell 42%, though adjusted results still topped analysts' estimates, as margins declined and the company saw a bigger loss from discontinued operations. The provider of drugs to nursing homes and assisted-living centers has struggled with falling earnings in recent quarters, hurt by litigation charges and other expenses. Omnicare reported a profit of $29.3 million, or 26 cents a share, down from $50.9 million, or 43 cents, a year earlier. Excluding litigation settlement and other items, earnings per share fell to 52 cents from 59 cents. Revenue rose 2.3% to $1.53 billion. Analysts polled by Thomson Reuters had most recently forecast earnings of 50 cents on $1.52 billion in revenue. Gross margin fell to 22.1% from 23%. The company's loss from discontinued operations widened to $21.2 million from $7.3 million in the year-earlier period. Shares were inactive premarket after closing the prior day at $32.71. As of the close, the stock had risen 15% the past year. -By Nathan Becker, Dow Jones Newswires; 212-416-2855; nathan.becker@dowjones.com;

Stock News for Omnicare (OCR)
DateTimeHeadline
05/22/201520:00:00SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into...
05/22/201517:28:30Current Report Filing (8-k)
05/22/201517:26:20Additional Proxy Soliciting Materials (definitive) (defa14a)
05/22/201517:10:19Additional Proxy Soliciting Materials (definitive) (defa14a)
05/22/201510:57:00SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation...
05/22/201510:27:00Finkelstein Thompson LLP Investigates Potentially Unfair Buyout...
05/22/201510:08:00SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders...
05/21/201520:30:46For CVS, Big Bet On Pricey Medicines
05/21/201517:10:00WeissLaw LLP: Omnicare, Inc. Sale Under Legal Investigation
05/21/201516:49:40Additional Proxy Soliciting Materials (definitive) (defa14a)
05/21/201516:45:20Additional Proxy Soliciting Materials (definitive) (defa14a)
05/21/201516:43:07Current Report Filing (8-k)
05/21/201516:39:40Additional Proxy Soliciting Materials (definitive) (defa14a)
05/21/201516:05:43Omnicare Declares Quarterly Cash Dividend
05/21/201514:40:00Robbins Arroyo LLP: Acquisition of Omnicare Inc. (OCR) by CVS...
05/21/201514:09:00Harwood Feffer LLP Announces Investigation of Omnicare, Inc.
05/21/201513:52:00OMNICARE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces...
05/21/201513:22:00INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation...
05/21/201512:56:00OMNICARE INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe...
05/21/201510:23:08CVS to Buy Omnicare For $12.7 Billion--5th Update

Omnicare and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad